🌀 Attention! Deal °86 IPO Prelude T. - for cancer treatment!
Stock market. Stocks. IPO Prelude Therapeutics — (PRLD) - September 25, 2020 on the American stock exchange will begin trading shares of the company (the deadline for submitting an application for participation with a broker is 20-00 Moscow time on 23.09.2020), which develops drugs for the treatment of cancer. The placement is underwritten by Morgan Stanley, Goldman Sachs and Bofasecuries. Company: Prelude Therapeutics (PLC) is a boutique Rating: 3 stars out scoop: 2 Oversubscription: 100% Allocation: up to 20%
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)